rs3750817
A SNP in the FGFR2 gene on chromosome 10. Its most notable genotype is T;T: 0.64x reduced risk for breast cancer, and higher likelihood of favorable postmenopausal hormone therapy
- Gene
- FGFR2
- Location
- Chr 10121,573,063 (GRCh38)
- Highest magnitude
- 2.4Worth knowing
- Tested on
- 23andMe, AncestryDNA, FamilyTreeDNA
- Minor allele frequency
- 34%
Genotypes
As shown in 23andMe and AncestryDNA files.
- C;CNot ratednormal
- C;TGood0.78x reduced risk for breast cancer
- T;TMost notableGood0.64x reduced risk for breast cancer, and higher likelihood of favorable postmenopausal hormone therapy
On SNPedia: (C;C), (C;T), (T;T). Magnitude rates how notable a genotype is from 0 to 10, not how risky it is.
Frequency
Share of each genotype in 11 HapMap populations.
- AverageC;C 53% C;T 34% T;T 13%
- European ancestry (Utah)C;C 43% C;T 43% T;T 14%
- Han Chinese (Beijing)C;C 22% C;T 52% T;T 26%
- Japanese (Tokyo)C;C 20% C;T 50% T;T 30%
- Yoruba (Nigeria)C;C 97% C;T 3% T;T 0%
- African ancestry (Southwest US)C;C 91% C;T 9% T;T 0%
- Chinese (Denver)C;C 17% C;T 53% T;T 30%
- Gujarati IndianC;C 31% C;T 53% T;T 17%
- Luhya (Kenya)C;C 94% C;T 6% T;T 0%
- Mexican ancestry (Los Angeles)C;C 36% C;T 50% T;T 14%
- Maasai (Kenya)C;C 86% C;T 14% T;T 0%
- TuscanC;C 45% C;T 43% T;T 12%
Related
Conditions, medicines and genes
Other FGFR2 SNPs
- rs2981582A;A1.7x higher risk of ER+ breast cancerImportant
- rs1219648G;G1.64x risk for breast cancerWorth knowing
- rs2420946T;T1.64x risk for breast cancerWorth knowing
- rs4752566G;Tassociated with thicker hair in AsiansMinor
- rs755793A;Acommon in complete genomicsTypical
- rs1047100T;Tcommon in clinvarTypical
- rs2303568A;Acommon in complete genomicsTypical
- rs2981578T;TnormalTypical
Notes
From SNPedia
Notes
rs3750817 is a SNP in the fibroblast growth factor receptor 2 FGFR2 gene. A study of 2,166 invasive breast cancer cases concluded that carriers of a rs3750817(T) allele had lower risk for cancer, with an estimated per-minor-allele odds ratio of 0.78. Success with hormone therapy to treat postmenopausal symptoms also correlated with the number of rs3750817(T) alleles. Common variation in the fibroblast growth factor receptor 2 gene is not associated with endometriosis risk.
Source and license
Adapted from rs3750817 on SNPedia, using a snapshot taken October 16, 2026. SNPedia content is shared under CC BY-NC-SA 3.0 US, and this page is shared under the same license.
SNPedia is a community-edited wiki. Its entries can be incomplete, out of date or wrong, and nothing here is a diagnosis or medical advice. Magnitude is a community rating of how interesting a genotype is, not a risk score.